Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Sci Transl Med ; 10(441)2018 05 16.
Artículo en Inglés | MEDLINE | ID: mdl-29769289

RESUMEN

Metastasis remains a leading cause of cancer mortality due to the lack of specific inhibitors against this complex process. To identify compounds selectively targeting the metastatic state, we used the perinucleolar compartment (PNC), a complex nuclear structure associated with metastatic behaviors of cancer cells, as a phenotypic marker for a high-content screen of over 140,000 structurally diverse compounds. Metarrestin, obtained through optimization of a screening hit, disassembles PNCs in multiple cancer cell lines, inhibits invasion in vitro, suppresses metastatic development in three mouse models of human cancer, and extends survival of mice in a metastatic pancreatic cancer xenograft model with no organ toxicity or discernable adverse effects. Metarrestin disrupts the nucleolar structure and inhibits RNA polymerase (Pol) I transcription, at least in part by interacting with the translation elongation factor eEF1A2. Thus, metarrestin represents a potential therapeutic approach for the treatment of metastatic cancer.


Asunto(s)
Nucléolo Celular/patología , Metástasis de la Neoplasia/tratamiento farmacológico , Pirimidinas/uso terapéutico , Pirroles/uso terapéutico , Animales , Línea Celular Tumoral , Nucléolo Celular/efectos de los fármacos , Nucléolo Celular/metabolismo , Nucléolo Celular/ultraestructura , Proliferación Celular/efectos de los fármacos , Cromatina/metabolismo , ADN Ribosómico/genética , Humanos , Masculino , Ratones , Invasividad Neoplásica , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patología , Factor 1 de Elongación Peptídica/metabolismo , Regiones Promotoras Genéticas/genética , Pirimidinas/química , Pirimidinas/farmacología , Pirroles/química , Pirroles/farmacología , ARN Polimerasa I/metabolismo , Precursores del ARN/biosíntesis , Análisis de Supervivencia , Transcripción Genética/efectos de los fármacos , Ensayos Antitumor por Modelo de Xenoinjerto
2.
J Biol Chem ; 292(10): 4302-4312, 2017 03 10.
Artículo en Inglés | MEDLINE | ID: mdl-28154170

RESUMEN

Transforming growth factor-ß (TGF-ß) signals through both SMAD and non-SMAD pathways to elicit a wide array of biological effects. Existing data have shown the association and coordination between STATs and SMADs in mediating TGF-ß functions in hepatic cells, but it is not clear how STATs are activated under these circumstances. Here, we report that JAK1 is a constitutive TGFßRI binding protein and is absolutely required for phosphorylation of STATs in a SMAD-independent manner within minutes of TGF-ß stimulation. Following the activation of SMADs, TGF-ß also induces a second phase of STAT phosphorylation that requires SMADs, de novo protein synthesis, and contribution from JAK1. Our global gene expression profiling indicates that the non-SMAD JAK1/STAT pathway is essential for the expression of a subset of TGF-ß target genes in hepatic stellate cells, and the cooperation between the JAK1-STAT3 and SMAD pathways is critical to the roles of TGF-ß in liver fibrosis.


Asunto(s)
Embrión de Mamíferos/patología , Células Estrelladas Hepáticas/patología , Janus Quinasa 1/metabolismo , Cirrosis Hepática/patología , Factor de Transcripción STAT3/metabolismo , Proteínas Smad/fisiología , Factor de Crecimiento Transformador beta/farmacología , Animales , Células Cultivadas , Embrión de Mamíferos/efectos de los fármacos , Embrión de Mamíferos/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Células Estrelladas Hepáticas/efectos de los fármacos , Células Estrelladas Hepáticas/metabolismo , Janus Quinasa 1/genética , Cirrosis Hepática/tratamiento farmacológico , Cirrosis Hepática/metabolismo , Ratones , Ratones Noqueados , Fosforilación/efectos de los fármacos , Factor de Transcripción STAT3/genética , Transducción de Señal/efectos de los fármacos
3.
Infect Immun ; 84(9): 2463-72, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27297394

RESUMEN

Immune modulation is a hallmark of patent filarial infection, including suppression of antigen-presenting cell function and downmodulation of filarial antigen-specific T cell responses. The mammalian target of rapamycin (mTOR) signaling pathway has been implicated in immune regulation, not only by suppressing T cell responses but also by regulating autophagy (through mTOR sensing amino acid availability). Global proteomic analysis (liquid chromatography-tandem mass spectrometry) of microfilaria (mf)-exposed monocyte-derived dendritic cells (DC) indicated that multiple components of the mTOR signaling pathway, including mTOR, eIF4A, and eIF4E, are downregulated by mf, suggesting that mf target this pathway for immune modulation in DC. Utilizing Western blot analysis, we demonstrate that similar to rapamycin (a known mTOR inhibitor), mf downregulate the phosphorylation of mTOR and its regulatory proteins, p70S6K1 and 4E-BP1, a process essential for DC protein synthesis. As active mTOR signaling regulates autophagy, we examined whether mf exposure alters autophagy-associated processes. mf-induced autophagy was reflected in marked upregulation of phosphorylated Beclin 1, known to play an important role in both autophagosome formation and autolysosome fusion, in induction of LC3II, a marker of autophagosome formation, and in induced degradation of p62, a ubiquitin-binding protein that aggregates protein in autophagosomes and is degraded upon autophagy that was reduced significantly by mf exposure and by rapamycin. Together, these results suggest that Brugia malayi mf employ mechanisms of metabolic modulation in DC to influence the regulation of the host immune response by downregulating mTOR signaling, resulting in increased autophagy. Whether this is a result of the parasite-secreted rapamycin homolog is currently under study.


Asunto(s)
Autofagia/fisiología , Brugia Malayi/parasitología , Células Dendríticas/parasitología , Microfilarias/fisiología , Serina-Treonina Quinasas TOR/metabolismo , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Animales , Proteínas Reguladoras de la Apoptosis/metabolismo , Autofagosomas/metabolismo , Autofagosomas/parasitología , Beclina-1/metabolismo , Proteínas de Ciclo Celular , Células Dendríticas/metabolismo , Regulación hacia Abajo/fisiología , Factor 4A Eucariótico de Iniciación/metabolismo , Factor 4E Eucariótico de Iniciación/metabolismo , Humanos , Lisosomas/metabolismo , Lisosomas/parasitología , Monocitos/metabolismo , Monocitos/parasitología , Fosfoproteínas/metabolismo , Fosforilación/fisiología , Proteómica/métodos , Proteínas Quinasas S6 Ribosómicas 70-kDa/metabolismo , Transducción de Señal/fisiología , Ubiquitina/metabolismo , Regulación hacia Arriba/fisiología
4.
Mol Cell ; 61(5): 747-759, 2016 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-26942678

RESUMEN

Erh1, the fission yeast homolog of Enhancer of rudimentary, is implicated in meiotic mRNA elimination during vegetative growth, but its function is poorly understood. We show that Erh1 and the RNA-binding protein Mmi1 form a stoichiometric complex, called the Erh1-Mmi1 complex (EMC), to promote meiotic mRNA decay and facultative heterochromatin assembly. To perform these functions, EMC associates with two distinct complexes, Mtl1-Red1 core (MTREC) and CCR4-NOT. Whereas MTREC facilitates assembly of heterochromatin islands coating meiotic genes silenced by the nuclear exosome, CCR4-NOT promotes RNAi-dependent heterochromatin domain (HOOD) formation at EMC-target loci. CCR4-NOT also assembles HOODs at retrotransposons and regulated genes containing cryptic introns. We find that CCR4-NOT facilitates HOOD assembly through its association with the conserved Pir2/ARS2 protein, and also maintains rDNA integrity and silencing by promoting heterochromatin formation. Our results reveal connections among Erh1, CCR4-NOT, Pir2/ARS2, and RNAi, which target heterochromatin to regulate gene expression and protect genome integrity.


Asunto(s)
Proteínas Portadoras/metabolismo , Ensamble y Desensamble de Cromatina , Heterocromatina/metabolismo , Meiosis , Interferencia de ARN , Estabilidad del ARN , ARN de Hongos/metabolismo , ARN Mensajero/metabolismo , Proteínas de Schizosaccharomyces pombe/metabolismo , Schizosaccharomyces/metabolismo , Factores de Escisión y Poliadenilación de ARNm/metabolismo , Proteínas Portadoras/genética , ADN Ribosómico/genética , ADN Ribosómico/metabolismo , Regulación Fúngica de la Expresión Génica , Heterocromatina/genética , Mutación , Conformación de Ácido Nucleico , Unión Proteica , ARN de Hongos/genética , ARN Mensajero/genética , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/metabolismo , Retroelementos , Schizosaccharomyces/genética , Schizosaccharomyces/crecimiento & desarrollo , Proteínas de Schizosaccharomyces pombe/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Factores de Escisión y Poliadenilación de ARNm/genética
5.
mBio ; 7(1): e02132-15, 2016 Feb 16.
Artículo en Inglés | MEDLINE | ID: mdl-26884435

RESUMEN

UNLABELLED: Immunoassays are currently needed to quantify Loa loa microfilariae (mf). To address this need, we have conducted proteomic and bioinformatic analyses of proteins present in the urine of a Loa mf-infected patient and used this information to identify putative biomarkers produced by L. loa mf. In total, 70 of the 15,444 described putative L. loa proteins were identified. Of these 70, 18 were L. loa mf specific, and 2 of these 18 (LOAG_16297 and LOAG_17808) were biologically immunogenic. We developed novel reverse luciferase immunoprecipitation system (LIPS) immunoassays to quantify these 2 proteins in individual plasma samples. Levels of these 2 proteins in microfilaremic L. loa-infected patients were positively correlated to mf densities in the corresponding blood samples (r = 0.71 and P < 0.0001 for LOAG_16297 and r = 0.61 and P = 0.0002 for LOAG_17808). For LOAG_16297, the levels in plasma were significantly higher in Loa-infected (geometric mean [GM], 0.045 µg/ml) than in uninfected (P < 0.0001), Wuchereria bancrofti-infected (P = 0.0005), and Onchocerca volvulus-infected (P < 0.0001) individuals, whereas for LOAG_17808 protein, they were not significantly different between Loa-infected (GM, 0.123 µg/ml) and uninfected (P = 0.06) and W. bancrofti-infected (P = 0.32) individuals. Moreover, only LOAG_16297 showed clear discriminative ability between L. loa and the other potentially coendemic filariae. Indeed, the specificity of the LOAG_16297 reverse LIPS assay was 96% (with a sensitivity of 77%). Thus, LOAG_16297 is a very promising biomarker that will be exploited in a quantitative point-of-care immunoassay for determination of L. loa mf densities. IMPORTANCE: Loa loa, the causative agent of loiasis, is a parasitic nematode transmitted to humans by the tabanid Chrysops fly. Some individuals infected with L. loa microfilariae (mf) in high densities are known to experience post-ivermectin severe adverse events (SAEs [encephalopathy, coma, or death]). Thus, ivermectin-based mass drug administration (MDA) programs for onchocerciasis and for lymphatic filariasis control have been interrupted in parts of Africa where these filarial infections coexist with L. loa. To allow for implementation of MDA for onchocerciasis and lymphatic filariasis, tools that can accurately identify people at risk of developing post-ivermectin SAEs are needed. Our study, using host-based proteomics in combination with novel immunoassays, identified a single Loa-specific antigen (LOAG_16297) that can be used as a biomarker for the prediction of L. loa mf levels in the blood of infected patients. Therefore, the use of such biomarker could be important in the point-of-care assessment of L. loa mf densities.


Asunto(s)
Antígenos Helmínticos/sangre , Biomarcadores/sangre , Loa/inmunología , Loa/aislamiento & purificación , Loiasis/diagnóstico , Loiasis/parasitología , África , Animales , Antígenos Helmínticos/inmunología , Biomarcadores/orina , Biología Computacional , Perfilación de la Expresión Génica , Proteínas del Helminto/sangre , Proteínas del Helminto/inmunología , Humanos , Inmunoensayo , Inmunoprecipitación , Loiasis/inmunología , Loiasis/orina , Microfilarias/inmunología , Microfilarias/aislamiento & purificación , Carga de Parásitos , Sistemas de Atención de Punto , Proteómica , Sensibilidad y Especificidad
6.
Sci Rep ; 5: 15916, 2015 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-26522388

RESUMEN

Prenylated proteins play key roles in several human diseases including cancer, atherosclerosis and Alzheimer's disease. KRAS4b, which is frequently mutated in pancreatic, colon and lung cancers, is processed by farnesylation, proteolytic cleavage and carboxymethylation at the C-terminus. Plasma membrane localization of KRAS4b requires this processing as does KRAS4b-dependent RAF kinase activation. Previous attempts to produce modified KRAS have relied on protein engineering approaches or in vitro farnesylation of bacterially expressed KRAS protein. The proteins produced by these methods do not accurately replicate the mature KRAS protein found in mammalian cells and the protein yield is typically low. We describe a protocol that yields 5-10 mg/L highly purified, farnesylated, and methylated KRAS4b from insect cells. Farnesylated and methylated KRAS4b is fully active in hydrolyzing GTP, binds RAF-RBD on lipid Nanodiscs and interacts with the known farnesyl-binding protein PDEδ.


Asunto(s)
Lípidos/fisiología , Prenilación de Proteína/fisiología , Proteínas Proto-Oncogénicas p21(ras)/metabolismo , Animales , Biofisica/métodos , Membrana Celular/metabolismo , Células Cultivadas , Guanosina Trifosfato/metabolismo , Humanos , Insectos/metabolismo , Metilación , Unión Proteica/fisiología , Quinasas raf/metabolismo
7.
PLoS Negl Trop Dis ; 9(9): e0004054, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26367142

RESUMEN

Filarial worms are parasitic nematodes that cause devastating diseases such as lymphatic filariasis (LF) and onchocerciasis. Filariae are nematodes with complex anatomy including fully developed digestive tracts and reproductive organs. To better understand the basic biology of filarial parasites and to provide insights into drug targets and vaccine design, we conducted a proteomic analysis of different anatomic fractions of Brugia malayi, a causative agent of LF. Approximately 500 adult female B. malayi worms were dissected, and three anatomical fractions (body wall, digestive tract, and reproductive tract) were obtained. Proteins from each anatomical fraction were extracted, desalted, trypsinized, and analyzed by microcapillary reverse-phase liquid chromatography-tandem-mass spectrometry. In total, we identified 4,785 B. malayi proteins. While 1,894 were identified in all three anatomic fractions, 396 were positively identified only within the digestive tract, 114 only within the body wall, and 1,011 only within the reproductive tract. Gene set enrichment analysis revealed a bias for transporters to be present within the digestive tract, suggesting that the intestine of adult filariae is functional and important for nutrient uptake or waste removal. As expected, the body wall exhibited increased frequencies of cytoskeletal proteins, and the reproductive tract had increased frequencies of proteins involved in nuclear regulation and transcription. In assessing for possible vaccine candidates, we focused on proteins sequestered within the digestive tract, as these could possibly represent "hidden antigens" with low risk of prior allergic sensitization. We identified 106 proteins that are enriched in the digestive tract and are predicted to localize to the surface of cells in the the digestive tract. It is possible that some of these proteins are on the luminal surface and may be accessible by antibodies ingested by the worm. A subset of 27 of these proteins appear especially promising vaccine candidates as they contain significant non-cytoplasmic domains, only 1-2 transmembrane domains, and a high degree of homology to W. bancrofti and/or O. volvulus.


Asunto(s)
Brugia Malayi/química , Proteoma/análisis , Animales , Cromatografía Liquida , Femenino , Tracto Gastrointestinal/química , Genitales/química , Proteómica , Espectrometría de Masas en Tándem
8.
J Immunol ; 194(8): 3594-600, 2015 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-25754738

RESUMEN

The expression level of HLA class-I proteins is known to influence pathological outcomes: pathogens downregulate HLA to evade host immune responses, host inflammatory reactions upregulate HLA, and differences among people with regard to the steady-state expression levels of HLA associate with disease susceptibility. Yet precise quantification of relative expression levels of the various HLA loci is difficult because of the tremendous polymorphism of HLA. We report relative expression levels of HLA-A, HLA-B, HLA-C, and HLA-E proteins for the specific haplotype A*02:01, B*44:02, C*05:01, which were characterized using two independent methods based on flow cytometry and mass spectrometry. PBLs from normal donors showed that HLA-A and HLA-B proteins are expressed at similar levels, which are 13-18 times higher than HLA-C by flow cytometry and 4-5 times higher than HLA-C by mass spectrometry; these differences may reflect variation in the conformation or location of proteins detected. HLA-E was detected at a level 25 times lower than that of HLA-C by mass spectrometry. Primary CD4(+) T cells infected with HIV in vitro were also studied because HIV downregulates selective HLA types. HLA-A and HLA-B were reduced on HIV-infected cells by a magnitude that varied between cells in an infected culture. Averaging all infected cells from an individual showed HLA-A to be 1-3 times higher and HLA-B to be 2-5 times higher than HLA-C by flow cytometry. These results quantify substantial differences in expression levels of the proteins from different HLA loci, which are very likely physiologically significant on both uninfected and HIV-infected cells.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Regulación de la Expresión Génica/inmunología , Sitios Genéticos/inmunología , Infecciones por VIH/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Linfocitos T CD4-Positivos/patología , Femenino , Citometría de Flujo , Infecciones por VIH/patología , Humanos , Masculino
9.
Cell ; 159(6): 1389-403, 2014 Dec 04.
Artículo en Inglés | MEDLINE | ID: mdl-25467444

RESUMEN

Telomere maintenance by telomerase is impaired in the stem cell disease dyskeratosis congenita and during human aging. Telomerase depends upon a complex pathway for enzyme assembly, localization in Cajal bodies, and association with telomeres. Here, we identify the chaperonin CCT/TRiC as a critical regulator of telomerase trafficking using a high-content genome-wide siRNA screen in human cells for factors required for Cajal body localization. We find that TRiC is required for folding the telomerase cofactor TCAB1, which controls trafficking of telomerase and small Cajal body RNAs (scaRNAs). Depletion of TRiC causes loss of TCAB1 protein, mislocalization of telomerase and scaRNAs to nucleoli, and failure of telomere elongation. DC patient-derived mutations in TCAB1 impair folding by TRiC, disrupting telomerase function and leading to severe disease. Our findings establish a critical role for TRiC-mediated protein folding in the telomerase pathway and link proteostasis, telomere maintenance, and human disease.


Asunto(s)
Chaperonina con TCP-1/metabolismo , Telomerasa/metabolismo , Telómero/metabolismo , Disqueratosis Congénita/genética , Disqueratosis Congénita/patología , Humanos , Hibridación Fluorescente in Situ , Chaperonas Moleculares , Pliegue de Proteína , Telomerasa/química
10.
Methods Mol Biol ; 1002: 181-93, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23625404

RESUMEN

Phosphorylation has long been accepted as a key cellular regulator of cell signaling pathways. The recent development of multiple-reaction monitoring mass spectrometry (MRM-MS) provides a useful tool for measuring the absolute quantity of phosphorylation occupancy at pivotal sites within signaling proteins, even when the phosphorylation sites are in close proximity. Here, we described a targeted quantitation approach to measure the absolute phosphorylation occupancy at Y1234 and Y1235 of Met. The approach is utilized to obtain absolute occupancy of the two phosphorylation sites in the full-length recombinant Met. It is further applied to quantitate the phosphorylation state of these two sites in SNU-5 cells treated with a Met inhibitor.


Asunto(s)
Espectrometría de Masas , Proteínas Proto-Oncogénicas c-met/metabolismo , Tirosina/metabolismo , Humanos , Fosforilación , Proteómica , Proteínas Proto-Oncogénicas c-met/genética , Tirosina/análisis , Tirosina/química
11.
Mol Cell Biol ; 32(10): 1928-43, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22431515

RESUMEN

The nuclear hormone receptor estrogen receptor α (ERα) mediates the actions of estrogens in target cells and is a master regulator of the gene expression and proliferative programs of breast cancer cells. The presence of ERα in breast cancer cells is crucial for the effectiveness of endocrine therapies, and its loss is a hallmark of endocrine-insensitive breast tumors. However, the molecular mechanisms underlying the regulation of the cellular levels of ERα are not fully understood. Our findings reveal a unique cellular pathway involving the p38 mitogen-activated protein kinase (p38MAPK)-mediated phosphorylation of ERα at Ser-294 that specifies its turnover by the SCF(Skp2) proteasome complex. Consistently, we observed an inverse relationship between ERα and Skp2 or active p38MAPK in breast cancer cell lines and human tumors. ERα regulation by Skp2 was cell cycle stage dependent and critical for promoting the mitogenic effects of estradiol via ERα. Interestingly, by the knockdown of Skp2 or the inhibition of p38MAPK, we restored functional ERα protein levels and the control of gene expression and proliferation by estrogen and antiestrogen in ERα-negative breast cancer cells. Our findings highlight a novel pathway with therapeutic potential for restoring ERα and the responsiveness to endocrine therapy in some endocrine-insensitive ERα-negative breast cancers.


Asunto(s)
Receptor alfa de Estrógeno/metabolismo , Complejo de la Endopetidasa Proteasomal/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Línea Celular Tumoral , Femenino , Humanos , Terapia Molecular Dirigida , Neoplasias Hormono-Dependientes/tratamiento farmacológico , Neoplasias Hormono-Dependientes/metabolismo , Fosforilación , Proteínas Quinasas Asociadas a Fase-S/metabolismo
12.
J Proteomics ; 74(12): 2650-9, 2011 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-21540133

RESUMEN

The search for protein biomarkers has been a highly pursued topic in the proteomics community in the last decade. This relentless search is due to the constant need for validated biomarkers that could facilitate disease risk stratification, disease diagnosis, prognosis, monitoring as well as drug development, which ultimately would improve our quality of life. The recent development of proteomic technologies including the advancement of mass spectrometers with high sensitivity and speed has greatly advanced the discovery of potential biomarkers. One of the bottlenecks lies in the development of well-established verification assays to screen the biomarker candidates identified in the discovery stage. Recently, absolute quantitation using multiple-reaction monitoring mass spectrometry (MRM-MS) in combination with isotope-labeled internal standards has been extensively investigated as a tool for high-throughput protein biomarker verification. In this review, we describe and discuss recent developments and applications of MRM-MS methods for biomarker verification.


Asunto(s)
Biomarcadores/metabolismo , Diseño de Fármacos , Espectrometría de Masas/métodos , Proteoma/metabolismo , Proteómica/métodos , Animales , Biomarcadores/análisis , Humanos , Proteoma/análisis
13.
Proc Natl Acad Sci U S A ; 108(23): 9649-54, 2011 Jun 07.
Artículo en Inglés | MEDLINE | ID: mdl-21606368

RESUMEN

Global proteomic analyses of pathogens have thus far been limited to unicellular organisms (e.g., protozoa and bacteria). Proteomic analyses of most eukaryotic pathogens (e.g., helminths) have been restricted to specific organs, specific stages, or secretomes. We report here a large-scale proteomic characterization of almost all the major mammalian stages of Brugia malayi, a causative agent of lymphatic filariasis, resulting in the identification of more than 62% of the products predicted from the Bm draft genome. The analysis also yielded much of the proteome of Wolbachia, the obligate endosymbiont of Bm that also expressed proteins in a stage-specific manner. Of the 11,610 predicted Bm gene products, 7,103 were definitively identified from adult male, adult female, blood-borne and uterine microfilariae, and infective L3 larvae. Among the 4,956 gene products (42.5%) inferred from the genome as "hypothetical," the present study was able to confirm 2,336 (47.1%) as bona fide proteins. Analysis of protein families and domains coupled with stage-specific expression highlight the important pathways that benefit the parasite during its development in the host. Gene set enrichment analysis identified extracellular matrix proteins and those with immunologic effects as enriched in the microfilarial and L3 stages. Parasite sex- and stage-specific protein expression identified those pathways related to parasite differentiation and demonstrates stage-specific expression by the Bm endosymbiont Wolbachia as well.


Asunto(s)
Proteínas Bacterianas/análisis , Brugia Malayi/metabolismo , Proteínas del Helminto/análisis , Proteoma/análisis , Proteómica/métodos , Wolbachia/metabolismo , Animales , Proteínas Bacterianas/clasificación , Brugia Malayi/crecimiento & desarrollo , Brugia Malayi/microbiología , Cromatografía Liquida/métodos , Análisis por Conglomerados , Femenino , Filariasis/parasitología , Proteínas del Helminto/clasificación , Interacciones Huésped-Patógeno , Humanos , Larva/crecimiento & desarrollo , Larva/metabolismo , Larva/microbiología , Estadios del Ciclo de Vida , Masculino , Proteoma/clasificación , Simbiosis , Espectrometría de Masas en Tándem , Wolbachia/fisiología
14.
BMC Genomics ; 12: 136, 2011 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-21362191

RESUMEN

BACKGROUND: Ticks--vectors of medical and veterinary importance--are themselves also significant pests. Tick salivary proteins are the result of adaptation to blood feeding and contain inhibitors of blood clotting, platelet aggregation, and angiogenesis, as well as vasodilators and immunomodulators. A previous analysis of the sialotranscriptome (from the Greek sialo, saliva) of Amblyomma variegatum is revisited in light of recent advances in tick sialomes and provides a database to perform a proteomic study. RESULTS: The clusterized data set has been expertly curated in light of recent reviews on tick salivary proteins, identifying many new families of tick-exclusive proteins. A proteome study using salivary gland homogenates identified 19 putative secreted proteins within a total of 211 matches. CONCLUSIONS: The annotated sialome of A. variegatum allows its comparison to other tick sialomes, helping to consolidate an emerging pattern in the salivary composition of metastriate ticks; novel protein families were also identified. Because most of these proteins have no known function, the task of functional analysis of these proteins and the discovery of novel pharmacologically active compounds becomes possible.


Asunto(s)
Perfilación de la Expresión Génica , Ixodidae/genética , Proteoma/genética , Proteínas y Péptidos Salivales/genética , Secuencia de Aminoácidos , Animales , Cromatografía Liquida , Biología Computacional , Bases de Datos de Proteínas , Femenino , Biblioteca de Genes , Datos de Secuencia Molecular , Espectrometría de Masas en Tándem
15.
J Proteome Res ; 10(2): 669-79, 2011 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-21058630

RESUMEN

Dipetalogaster maxima is a blood-sucking Hemiptera that inhabits sylvatic areas in Mexico. It usually takes its blood meal from lizards, but following human population growth, it invaded suburban areas, feeding also on humans and domestic animals. Hematophagous insect salivary glands produce potent pharmacologic compounds that counteract host hemostasis, including anticlotting, antiplatelet, and vasodilatory molecules. To obtain further insight into the salivary biochemical and pharmacologic complexity of this insect, a cDNA library from its salivary glands was randomly sequenced. Salivary proteins were also submitted to one- and two-dimensional gel electrophoresis (1DE and 2DE) followed by mass spectrometry analysis. We present the analysis of a set of 2728 cDNA sequences, 1375 of which coded for proteins of a putative secretory nature. The saliva 2DE proteome displayed approximately 150 spots. The mass spectrometry analysis revealed mainly lipocalins, pallidipins, antigen 5-like proteins, and apyrases. The redundancy of sequence identification of saliva-secreted proteins suggests that proteins are present in multiple isoforms or derive from gene duplications.


Asunto(s)
Proteínas de Insectos/análisis , Proteoma/análisis , Triatominae/metabolismo , Secuencia de Aminoácidos , Animales , Análisis por Conglomerados , Electroforesis en Gel de Poliacrilamida , Perfilación de la Expresión Génica , Biblioteca de Genes , Proteínas de Insectos/clasificación , Proteínas de Insectos/metabolismo , Espectrometría de Masas , Datos de Secuencia Molecular , Mapeo Peptídico , Proteoma/metabolismo , ARN Mensajero/química , ARN Mensajero/aislamiento & purificación , Glándulas Salivales/química , Glándulas Salivales/metabolismo , Alineación de Secuencia
16.
J Proteomics ; 73(1): 112-22, 2009 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-19709643

RESUMEN

Proteomic profiling of membrane proteins is of vital importance in the search for disease biomarkers and drug development. However, the slow pace in this field has resulted mainly from the difficulty to analyze membrane proteins by mass spectrometry (MS). The objective of this investigation was to explore and optimize solubilization of membrane proteins for shotgun membrane proteomics of the CD14 human monocytes by examining different systems that rely on: i) an organic solvent (methanol) ii) an acid-labile detergent 3-[3-(1,1-bisalkyloxyethyl)pyridin-1-yl]propane-1-sulfonate (PPS), iii) a combination of both agents (methanol+PPS). Solubilization efficiency of different buffers was first compared using bacteriorhodopsin as a model membrane protein. Selected approaches were then applied on a membrane subproteome isolated from a highly enriched human monocyte population that was approximately 98% positive for CD14 expression as determined by FACS analysis. A methanol-based buffer yielded 194 proteins of which 93 (48%) were mapped as integral membrane proteins. The combination of methanol and acid-cleavable detergent gave similar results; 203 identified proteins of which 93 (46%) were mapped integral membrane proteins. However, employing PPS 216 proteins were identified of which 75 (35%) were mapped as integral membrane proteins. These results indicate that methanol alone or in combination with PPS yielded significantly higher membrane protein identification/enrichment than the PPS alone.


Asunto(s)
Receptores de Lipopolisacáridos/análisis , Proteínas de la Membrana/aislamiento & purificación , Proteínas de la Membrana/metabolismo , Monocitos/metabolismo , Proteómica/métodos , Espectrometría de Masas en Tándem/métodos , Bacteriorodopsinas/química , Bacteriorodopsinas/metabolismo , Calibración , Caseínas/metabolismo , Cromatografía Liquida/métodos , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Receptores de Lipopolisacáridos/química , Proteínas de la Membrana/química , Monocitos/química , Hidrolisados de Proteína/metabolismo , Proteoma/análisis , Proteoma/química , Proteómica/normas , Solubilidad
17.
Nature ; 460(7251): 66-72, 2009 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-19571879

RESUMEN

Stem cells are controlled, in part, by genetic pathways frequently dysregulated during human tumorigenesis. Either stimulation of Wnt/beta-catenin signalling or overexpression of telomerase is sufficient to activate quiescent epidermal stem cells in vivo, although the mechanisms by which telomerase exerts these effects are not understood. Here we show that telomerase directly modulates Wnt/beta-catenin signalling by serving as a cofactor in a beta-catenin transcriptional complex. The telomerase protein component TERT (telomerase reverse transcriptase) interacts with BRG1 (also called SMARCA4), a SWI/SNF-related chromatin remodelling protein, and activates Wnt-dependent reporters in cultured cells and in vivo. TERT serves an essential role in formation of the anterior-posterior axis in Xenopus laevis embryos, and this defect in Wnt signalling manifests as homeotic transformations in the vertebrae of Tert(-/-) mice. Chromatin immunoprecipitation of the endogenous TERT protein from mouse gastrointestinal tract shows that TERT physically occupies gene promoters of Wnt-dependent genes. These data reveal an unanticipated role for telomerase as a transcriptional modulator of the Wnt/beta-catenin signalling pathway.


Asunto(s)
Cromatina/genética , Transducción de Señal , Telomerasa/metabolismo , Proteínas Wnt/metabolismo , Animales , Línea Celular , Coristoma/genética , Coristoma/patología , ADN Helicasas/metabolismo , Genes Reporteros/genética , Células HeLa , Humanos , Intestino Delgado/metabolismo , Ratones , Proteínas Nucleares/metabolismo , Oocitos/citología , Oocitos/crecimiento & desarrollo , Plásmidos/genética , Regiones Promotoras Genéticas/genética , Somitos/anomalías , Somitos/embriología , Factores de Transcripción/metabolismo , Proteínas Wnt/genética , Proteína Wnt3 , Xenopus laevis/embriología , beta Catenina/genética
18.
PLoS Negl Trop Dis ; 3(4): e410, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19352421

RESUMEN

Relatively little is known about the filarial proteins that interact with the human host. Although the filarial genome has recently been completed, protein profiles have been limited to only a few recombinants or purified proteins of interest. Here, we describe a large-scale proteomic analysis using microcapillary reverse-phase liquid chromatography-tandem-mass spectrometry to identify the excretory-secretory (ES) products of the L3, L3 to L4 molting ES, adult male, adult female, and microfilarial stages of the filarial parasite Brugia malayi. The analysis of the ES products from adult male, adult female, microfilariae (Mf), L3, and molting L3 larvae identified 852 proteins. Annotation suggests that the functional and component distribution was very similar across each of the stages studied; however, the Mf contributed a higher proportion to the total number of identified proteins than the other stages. Of the 852 proteins identified in the ES, only 229 had previous confirmatory expressed sequence tags (ESTs) in the available databases. Moreover, this analysis was able to confirm the presence of 274 "hypothetical" proteins inferred from gene prediction algorithms applied to the B. malayi (Bm) genome. Not surprisingly, the majority (160/274) of these "hypothetical" proteins were predicted to be secreted by Signal IP and/or SecretomeP 2.0 analysis. Of major interest is the abundance of previously characterized immunomodulatory proteins such as ES-62 (leucyl aminopeptidase), MIF-1, SERPIN, glutathione peroxidase, and galectin in the ES of microfilariae (and Mf-containing adult females) compared to the adult males. In addition, searching the ES protein spectra against the Wolbachia database resulted in the identification of 90 Wolbachia-specific proteins, most of which were metabolic enzymes that have not been shown to be immunogenic. This proteomic analysis extends our knowledge of the ES and provides insight into the host-parasite interaction.


Asunto(s)
Brugia Malayi/química , Brugia Malayi/crecimiento & desarrollo , Proteínas del Helminto/metabolismo , Interacciones Huésped-Patógeno , Proteoma/análisis , Animales , Cromatografía Liquida , Eritrocitos , Femenino , Masculino , Espectrometría de Masas
19.
J Proteome Res ; 8(3): 1474-88, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19166301

RESUMEN

Adaptation to vertebrate blood feeding includes development of a salivary "magic potion" that can disarm host hemostasis and inflammatory reactions. Within the lower Diptera, a vertebrate blood-sucking mode evolved in the Psychodidae (sand flies), Culicidae (mosquitoes), Ceratopogonidae (biting midges), Simuliidae (black flies), and the frog-feeding Corethrellidae. Sialotranscriptome analyses from several species of mosquitoes and sand flies and from one biting midge indicate divergence in the evolution of the blood-sucking salivary potion, manifested in the finding of many unique proteins within each insect family, and even genus. Gene duplication and divergence events are highly prevalent, possibly driven by vertebrate host immune pressure. Within this framework, we describe the sialome (from Greek sialo, saliva) of the black fly Simulium vittatum and discuss the findings within the context of the protein families found in other blood-sucking Diptera. Sequences and results of Blast searches against several protein family databases are given in Supplemental Tables S1 and S2, which can be obtained from http://exon.niaid.nih.gov/transcriptome/S_vittatum/T1/SV-tb1.zip and http://exon.niaid.nih.gov/transcriptome/S_vittatum/T2/SV-tb2.zip .


Asunto(s)
Biblioteca de Genes , Proteoma/metabolismo , Saliva/metabolismo , Glándulas Salivales/metabolismo , Simuliidae/fisiología , Secuencia de Aminoácidos , Animales , Electroforesis en Gel de Poliacrilamida , Datos de Secuencia Molecular , Filogenia , Espectrometría de Masas en Tándem
20.
Science ; 323(5914): 644-8, 2009 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-19179534

RESUMEN

Telomerase is a ribonucleoprotein (RNP) complex that synthesizes telomere repeats in tissue progenitor cells and cancer cells. Active human telomerase consists of at least three principal subunits, including the telomerase reverse transcriptase, the telomerase RNA (TERC), and dyskerin. Here, we identify a holoenzyme subunit, TCAB1 (telomerase Cajal body protein 1), that is notably enriched in Cajal bodies, nuclear sites of RNP processing that are important for telomerase function. TCAB1 associates with active telomerase enzyme, established telomerase components, and small Cajal body RNAs that are involved in modifying splicing RNAs. Depletion of TCAB1 by using RNA interference prevents TERC from associating with Cajal bodies, disrupts telomerase-telomere association, and abrogates telomere synthesis by telomerase. Thus, TCAB1 controls telomerase trafficking and is required for telomere synthesis in human cancer cells.


Asunto(s)
Cuerpos Enrollados/metabolismo , Telomerasa/metabolismo , Telómero/metabolismo , Secuencia de Aminoácidos , Proteínas de Ciclo Celular/metabolismo , Línea Celular Tumoral , Células HeLa , Humanos , Inmunoprecipitación , Chaperonas Moleculares , Datos de Secuencia Molecular , Proteínas Nucleares/metabolismo , ARN/metabolismo , Interferencia de ARN , Telomerasa/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...